Kura Oncology, Inc. (KURA)
NASDAQ: KURA · Real-Time Price · USD
9.68
+0.74 (8.28%)
At close: Apr 17, 2026, 4:00 PM EDT
9.59
-0.09 (-0.93%)
Pre-market: Apr 20, 2026, 7:48 AM EDT
Kura Oncology Market Cap
Kura Oncology has a market cap or net worth of $859.22 million as of April 20, 2026. Its market cap has increased by 63.20% in one year.
Market Cap
859.22M
Enterprise Value
212.44M
1-Year Change
63.20%
Ranking
Category
Stock Price
$9.68
Market Cap Chart
Since November 5, 2015, Kura Oncology's market cap has increased from $113.70M to $859.22M, an increase of 655.69%. That is a compound annual growth rate of 21.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 855.00M | -5.43% |
| Dec 31, 2025 | 904.10M | 33.49% |
| Dec 31, 2024 | 677.30M | -36.58% |
| Dec 29, 2023 | 1.07B | 28.64% |
| Dec 30, 2022 | 830.20M | -10.90% |
| Dec 31, 2021 | 931.80M | -49.69% |
| Dec 31, 2020 | 1.85B | 197.24% |
| Dec 31, 2019 | 623.10M | 16.69% |
| Dec 31, 2018 | 534.00M | 15.51% |
| Dec 29, 2017 | 462.30M | 266.61% |
| Dec 30, 2016 | 126.10M | -29.75% |
| Dec 31, 2015 | 179.50M | 57.87% |
| Nov 5, 2015 | 113.70M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cullinan Therapeutics | 907.89M |
| SELLAS Life Sciences Group | 895.22M |
| Maravai LifeSciences Holdings | 880.46M |
| Theravance Biopharma | 870.23M |
| SpyGlass Pharma | 865.08M |
| MannKind | 863.08M |
| Bright Minds Biosciences | 851.14M |
| Vor Biopharma | 850.17M |